-
Alzheimer’s disease no longer considered untreatableUnder the Radar Treatment options are expanding, and experts are turning their attention to prevention
Under the Radar -
FDA estrogen warning’s impact on menopausal UTI deathsUnder the Radar The black-label warning may be gone, but the stigma still endangers older women
Under the Radar -
White House ousts 760K from ACA, claiming fraudSpeed Read Vice President JD Vance said those removed were “phantom people” and “real people who just don’t meet the eligibility requirements”
Speed Read -
Fiji declares national emergency as drugs and stigma fuel HIV outbreakThe Explainer As new HIV diagnoses skyrocket, the government is focusing on community advocacy
The Explainer -
AI may have cracked the antiaging codeIn the Spotlight An AI-discovered drug could help slow the aging process
In the Spotlight -
Why GLP-1s don’t work for everyoneThe Explainer Some people aren’t responding to the drugs at all, no matter if they try Wegovy or Zepbound
The Explainer -
Why an infamous California rollercoaster has closedUnder The Radar Complaints of serious brain injuries in riders span two decades
Under The Radar -
School dinners are about to get even healthierThe Explainer A ‘shocking’ recent report found that three-quarters of secondary schools are already flouting guidelines – as new government rules tighten them further
The Explainer -
Letters ‘refute’ RFK Jr’s Samoa vaccine testimonySpeed Read The HHS secretary once said his trip to Samoa was unrelated to vaccines
Speed Read -
The Ebola outbreak: ‘a perfect storm’Talking Point This has been the fastest-growing outbreak of the disease ever, but the silence around it is ‘astounding’
Talking Point -
FDA approves landmark pancreatic cancer drugSpeed Read A clinical trial saw patients on the drug live a median of 13.2 months
Speed Read -
DEI clashes lead to funding cuts for Alzheimer’s researchThe Explainer At least two major research institutions have been hit with cuts
The Explainer -
A ‘pivotal moment’ for personalised cancer vaccinesThe Explainer Early results from final-stage trial of individualised melanoma jab offer hope of more tailor-made cancer treatments
The Explainer -
Moderna says skin cancer vaccine trial a successSpeed Read The experimental vaccine successfully reduced the recurrence of melanoma, the company said
Speed Read
